Obermatt

Astrana Health

NAQ:ASTH · US03763A2078
Health Care Providers & ServicesMedium

360

62
EV / EBIT59
Price / Owner Earnings26
Owner Earnings Yield56
Dividend Yield85
Price/Sales86
EV / Gross Profit39
Price/Book60
Return on Capital62
Cash Return on Capital55
Return on Equity49
EBIT Margin39
Gross Profitability15
Cash Conversion88
Accruals3
Owner Earnings Margin41
Sales growth81
Profit Growth43
Long-Term EPS Growth91
Owner Earnings Growth75
Reinvestment80
Price momentum58
Debt load19
Refinancing11
Debt Payback34
Liquidity39
Analyst ratings78
Opinion Changes61
Price Target Upside39
Market mood63
Value Creation14/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Astrana Health generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
TypePublic Company
ExchangeNASDAQCM
Employees586
ISINUS03763A2078
Last UpdateApr 2, 2026
Themes
Outpatient CareChronic DiseasesHealth CareMedical

Description

Astrana Health, Inc. (Astrana) operates as a physician-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables…

Analysis

Middle-of-the-road

Astrana Health, Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is expensive. You pay 26.8× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 10% yearly growth; analysts expect 82%. The price, in other words, assumes less than the experts do.

The trajectory is solid and the balance sheet is stretched. The company scores 14/20 on our value-creation score: strong value creator.

What to watch: The financial cushion is thinner than comfortable. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
80
2023202420252026

All-time high

100

Jan 2025

All-time low

28

Mar 2026

Average rank

72

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
86
55
44
19
Price/Earnings
63
23
25
12
Price/Book
60
30
17
25
Dividend Yield
85
69
90
1
Value (overall)
96
41
54
6

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Astrana Health with its peers
Privia Health
NSQ:PRVA
43
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Chemed
NYQ:CHE
75
CountryUSA
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Quest Diagnostics
NYQ:DGX
35
CountryUSA
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
GeneDx
NSQ:WGS
6
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
DaVita
NYQ:DVA
40
CountryUSA
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
RadNet
NMQ:RDNT
14
CountryUSA
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →